
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
PYRAZOLE DERIVATIVES AS AN ENOYL ACYL CARRIER PROTEIN REDUCTASE (INHA) INHIBITORS WITH PROMISING ANTITUBERCULAR ACTIVITY
Kinjal Nayee*, Beenkumar Prajapati and Haribhai Rabari
. Abstract Tuberculosis is an infectious disease caused by bacillus Mycobacterium tuberculosis (MTB). New drugs with different mechanisms of action against tuberculosis must be discovered and developed in response to the rising prevalence of multidrug-resistant MTB. Several pyrazole derivatives have been synthesized and tested for anti-tubercular activity in past years. Enoyl acyl carrier protein reductase (InhA), is a clinically proven target for tuberculosis treatment. This review outlines the effectiveness of pyrazole derivatives as an InhA inhibitors and their antitubercular potential. Keywords: Tuberculosis, Pyrazole, Enoyl Acyl Carrier Protein Reductase (InhA), Antitubercular Activity. [Full Text Article] [Download Certificate] |
